Cancer · Austria
Acute myeloid leukaemia
How is it diagnosed today? Your family doctor usually arranges an urgent blood test, and may send you to a hospital specialist or straight to hospital. NHS
What do you need help with?
- Join a trialStudies open to new patients in your country, and abroad if you want.13 open trials in Austria
- Offer tissue or dataGive a sample or your health data to research.
- Get supportPatient groups, money and work, help for family.
- Access and costGetting a treatment that is not on offer here, and who pays.
- Questions for your doctorReady lists to print or copy before your next visit.
- Don't pay for thisOffers with no proof in people, and what to check first.
Where treatment stands
Four steps, from proven to unproven.
Approved in Austria
Usual treatment: Intensive chemo, sometimes a stem cell transplant. NHS
15 medicines are approved for this disease in Austria:
Show all 15
- Arsenic trioxide (Trisenox, Arsenic trioxide Accord, Arsenic trioxide medac) – approved in 2002
- Azacitidine (Onureg, Azacitidine Mylan, Azacitidine Kabi) – approved in 2008
- Cedazuridine and decitabine (Inaqovi, Inqovi) – approved in 2023
- Daunorubicin and cytarabine (Vyxeos liposomal, Vyxeos) – approved in 2018
- Decitabine (Dacogen, Decitabin Sandoz) – approved in 2012
- Gemtuzumab ozogamicin (Mylotarg) – approved in 2018
- Gilteritinib (Xospata) – approved in 2019
- Glasdegib (Daurismo) – approved in 2020
- Histamine dihydrochloride (Ceplene) – approved in 2008
- Ivosidenib (Tibsovo) – approved in 2023
- Melphalan (Phelinun) – approved in 2020
- Midostaurin (Rydapt) – approved in 2017
- Quizartinib (Vanflyta) – approved in 2023
- Venetoclax (Venclyxto, Venclexta) – approved in 2016
- Posaconazole (Noxafil, Posaconazole Accord, Posaconazole AHCL) – approved in 2005
An EU approval is valid in Austria. We did not check the national approvals in Austria, so some medicines under “Approved elsewhere” may be approved here too. We did not check whether they are sold or paid for there. Checked in the regulators' own texts on 11 Nov 2026.
Approved elsewhere (17)
- Cyclophosphamide (Frindovyx) – approved for it in the US
- Cytarabine (Cytarabine, Aracytine, Cytarabine Sandoz) – approved for it in the US and France
- Daunorubicin (Daunorubicin Hydrochloride, Daunoblastin, Cerubidine) – approved for it in the US, Switzerland, and France
- Doxorubicin (Doxorubicin Hydrochloride) – approved for it in the US
- Enasidenib (Idhifa) – approved for it in the US
- Etoposide (Celltop, Etopophos) – approved for it in France
- Filgrastim (Neupogen) – approved for it in the US
- Idarubicin (Zavedos, Idamycin PFS, Idarubicine Accord) – approved for it in the US and France
- Mercaptopurine (Purinethol) – approved for it in France
- Mitoxantrone (mitoXANTRONE) – approved for it in the US
- Olutasidenib (Rezlidhia) – approved for it in the US
- Revumenib (Revuforj) – approved for it in the US
- Sargramostim (Leukine) – approved for it in the US
- Thioguanine (Tabloid, Lanvis) – approved for it in the US and France
- Treosulfan (Grafapex) – approved for it in the US
- Tretinoin (Tretinoin, Vesanoid) – approved for it in the US, Switzerland, and France
- Ziftomenib (Komzifti) – approved for it in the US
Being tested in people
13 open trials in Austria, 635 worldwide. See the trials
- 4 chemotherapy blocks: Course 1 AIE (cytarabine/idarubicin/etoposide), Course 2 AI (cytarabine/idarubicin), Course 3 HAD (high-dose cytarabine (1g)/daunorubicin), Course 4 HA (high-dose cytarabine). (Phase 3)
- AG-120 (Phase 3)
- AG-221 (Phase 3)
- all-trans retinoic acid (ATRA) (Phase 3)
Only in the lab or in animals
Of the 20 newest articles, 2 were in animals and 1 in the lab. See them
No proof it works
Animal worm medicines (ivermectin, fenbendazole) for cancer: not approved, and not enough research in people to know if they help. American Cancer Society: What to Know About Ivermectin (21 May 2026) · American Cancer Society: What to Know About Fenbendazole (21 Oct 2025)
Join a trial
Studies that are taking new patients in Austria. The trial team decides who can join. Change the country at the top.
Phase 1: first tests in people · Phase 2: does it help? · Phase 3: compared with the usual treatment
3 open trials in Austria with these filters
Tests revumenib with chemotherapy for newly diagnosed acute myeloid leukemia with NPM1 mutation
NCT07211958 · ClinicalTrials.gov
- Graz – Medical University of Graz
- Innsbruck – Medizinische Universitaet Innsbruck
- Linz – Ordensklinikum Linz GmbH
- and 1 more site
Age 12 and over
Contact the trial teamTests ziftomenib with chemotherapy in children with relapsed acute leukemia
NCT06376162 · ClinicalTrials.gov
- Vienna – St. Anna Kinderspital GmbH
Ages 0 to 21
Contact the trial teamRevumenib plus chemotherapy for children with relapsed or resistant acute myeloid leukemia
2025-521390-14-00 · EU Clinical Trials Register
- Vienna – St. Anna Kinderspital GmbH
Up to age 64
Contact the trial team
Available abroad (213 trials)
Nearest region first. Travel and treatment abroad are often not paid for; ask your health insurer first.
Tests ponatinib in children with hard-to-treat leukemias, lymphomas or solid tumors
NCT03934372 · ClinicalTrials.gov
Countries: Belgium, Spain, France and 4 more
- Ghent, Belgium – Ghent university hospital
- Barcelona, Spain – Hospital General Universitario Vall D Hebron
- Barcelona, Spain – Hospital Sant Joan de Deu de Manresa
Ages 1 to 17
Contact the trial teamTesting JNJ-95804306 in Blood Cancers That Returned or Did Not Respond to Treatment
2026-525234-39-00 · EU Clinical Trials Register
Countries: Belgium, Germany, Denmark and 2 more
- Edegem, Belgium – Universitair Ziekenhuis Antwerpen
- Leuven, Belgium – UZ Leuven
- Berlin, Germany – Charite Universitaetsmedizin Berlin KöR
No age limit given in the registry
Contact the trial teamObserves outcomes in people with relapsed or refractory acute myeloid leukemia
NCT06459024 · ClinicalTrials.gov
Countries: Germany, Spain, Italy and 4 more
- Aachen, Germany – University Hospital Aachen
- Greifswald, Germany – University Hospital Greifswald
- Halle, Germany – University Hospital Halle
Age 6 and over
Contact the trial teamMeasuring the CD180 protein on blood cells in acute myeloid leukemia
NCT07895901 · ClinicalTrials.gov
Countries: France
- Strasbourg, France – Laboratoire d'Hématologie Biologique - CHU de Strasbourg - France
Age 1 and over
Contact the trial teamTests AZD3632 alone or with other drugs in advanced blood cancers
NCT07155226 · ClinicalTrials.gov
Countries: Germany, United Kingdom, Italy and 5 more
- Dresden, Germany – Technische Universitaet Dresden
- Frankfurt Am Main, Germany – Goethe University Frankfurt
- Heidelberg, Germany – Universitaetsklinikum Heidelberg AöR
Age 16 and over
Contact the trial teamCAR-cell infusion for leukemia and BPDCN that returned or did not respond
NCT07877610 · ClinicalTrials.gov
Countries: Italy
- Bergamo, Italy – Asst Papa Giovanni XXIII
- Monza, Italy – Fondazione IRCCS San Gerardo dei Tintori
Ages 0 to 75
Contact the trial teamTeicoplanin to Prevent Infections in Children with Acute Myeloid Leukemia
2023-506546-23-00 · EU Clinical Trials Register
Countries: Belgium, Denmark, Spain and 1 more
- Leuven, Belgium – UZ Leuven
- Aarhus N, Denmark – Aarhus Universitetshospital
- Alicante, Spain – Hospital General Universitario Dr. Balmis
Up to age 64
Contact the trial teamTests revumenib in people with relapsed or hard-to-treat acute leukemia
NCT04065399 · ClinicalTrials.gov
Countries: Germany, Spain, France and 7 more
- Hamburg, Germany – University Medical Center Hamburg-Eppendorf
- Leipzig, Germany – Universitaet Leipzig
- Mainz, Germany – Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz KöR
Age 0 and over
Contact the trial teamPivekimab sunirine for children with acute myeloid leukemia that returned or did not respond
NCT07306832 · ClinicalTrials.gov
Countries: France, United Kingdom, Italy and 4 more
- Bordeaux, France – Chu Bordeaux - Hopital Pellegrin
- Paris, France – Hopital Armand Trousseau
- Cambridge, United Kingdom – Cambridge University Hospital
Ages 0 to 17
Contact the trial teamFollows people with GATA2 gene mutation to study how blood changes over time
NCT05983991 · ClinicalTrials.gov
Countries: France
- Angers, France – CHU Angers
- Bordeaux, France – CHU Bordeaux
- Caen, France – CHU de CAEN
No age limit given in the registry
Contact the trial teamTests treatment plans for children and teens with acute myeloid leukemia
2023-504999-25-00 · EU Clinical Trials Register
Countries: Belgium, Denmark, Estonia and 7 more
- Brussels, Belgium – Association Hospitaliere De Bruxelles Hopital Universitaire Des Enfants Reine Fabiola
- Leuven, Belgium – UZ Leuven
- Liège, Belgium – CHC MontLégia
Up to age 64
Contact the trial teamCARCIK-CD123/33 cell therapy for relapsed or resistant acute myeloid leukemia and BPDCN
2025-524977-18-00 · EU Clinical Trials Register
Countries: Italy
- Bergamo, Italy – Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII
- Monza, Italy – Fondazione IRCCS San Gerardo dei Tintori
No age limit given in the registry
Contact the trial teamPivekimab Sunirine for Children and Teens With Acute Myeloid Leukemia That Returned
2024-520125-36-00 · EU Clinical Trials Register
Countries: Czechia, Spain, France and 2 more
- Prague, Czechia – Fakultni Nemocnice Motol a Homolka
- Esplugues de Llobregat, Spain – Hospital Sant Joan De Deu Barcelona
- Madrid, Spain – Hospital Infantil Universitario Nino Jesus
Up to age 17
Contact the trial teamTests two ways to prevent graft-versus-host disease after donor stem cell transplant
NCT04888741 · ClinicalTrials.gov
Countries: United Kingdom
- Birmingham, United Kingdom – Queen Elizabeth Hospital
- Bristol, United Kingdom – Bristol Haematology and Oncology Centre
- Cambridge, United Kingdom – Addenbrookes Hospital
Ages 16 to 70
Contact the trial teamGenetic Testing for Inherited Risk in Families With Leukemia
NCT03058588 · ClinicalTrials.gov
Countries: Italy
- Brescia, Italy – Chair of Hematology and Bone marrow Transplant Unit
No age limit given in the registry
Contact the trial teamTests enzomenib in people with acute leukemia or related blood cancers
NCT04988555 · ClinicalTrials.gov
Countries: Belgium, Switzerland, Spain and 9 more
- Antwerp, Belgium – ZNA Cadix
- Ghent, Belgium – UZ Ghent
- Leuven, Belgium – University Hospitals Leuven
Age 12 and over
Contact the trial teamCord blood transplant with extra white blood cells for hard-to-treat leukemia in young adults
NCT07372885 · ClinicalTrials.gov
Countries: United Kingdom
- London, United Kingdom – Kings College Hospital NHS Trust
- London, United Kingdom – The Royal Marsden Hospital NHS Foundation Trust
- Manchester, United Kingdom – The Christie NHS Foundation Trust
Ages 16 to 55
Contact the trial teamTests donor immune cells to prevent graft-versus-host disease in children with leukemia
NCT07366801 · ClinicalTrials.gov
Countries: Russia
- Moscow, Russia – National medical research center of pediatric haematology, oncology and immulogy named after Dmytriy Rogachyov, Moscow, 117198
Ages 1 to 25
Contact the trial teamDonor immune cell infusions with stem cell transplant for acute leukemia
NCT07256210 · ClinicalTrials.gov
Countries: Russia
- Moscow, Russia – Dmitry Rogachev Federal Research and Clinical Centre of Paediatric Haematology, Oncology and Immunology
Ages 0 to 25
Contact the trial teamVenetoclax blood levels and side effects in acute myeloid leukemia in remission
NCT07254312 · ClinicalTrials.gov
Countries: Italy
- Pavia, Italy – Fondazione IRCCS Policlinico San Matteo, SC Oncologia
No age limit given in the registry
Contact the trial teamStudies bone marrow samples from children with acute leukemia
NCT05792007 · ClinicalTrials.gov
Countries: France
- Tours, France – Service d'onco-hématologie pédiatrique -CHRU Tours
- Tours, France – Service de chirurgie orthopédique pédiatrique -CHRU TOURS
- Tours, France – Service d'hématologie biologique-CHRU TOURS
Ages 1 to 15
Contact the trial teamTests chemotherapy in children with acute myeloid leukemia and Down syndrome
NCT07232134 · ClinicalTrials.gov
Countries: Russia
- Moscow, Russia – National medical research center of pediatric haematology, oncology and immulogy named after Dmytriy Rogachyov, Moscow, 117198
Ages 0 to 18
Contact the trial teamTesting new treatment combinations for children with newly diagnosed acute myeloid leukemia
NCT05994690 · ClinicalTrials.gov
Countries: Netherlands
- Utrecht, Netherlands – Princess Máxima Center for Pediatric Oncology
Ages 0 to 18
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamTests quizartinib with chemotherapy in children with newly diagnosed leukemia
NCT06262438 · ClinicalTrials.gov
Countries: Belgium, Denmark, Estonia and 7 more
- Brussels, Belgium – Association Hospitaliere De Bruxelles Hopital Universitaire Des Enfants Reine Fabiola
- Leuven, Belgium – UZ Leuven
- Liège, Belgium – Centre Hospitalier Regional de la Citadelle
Ages 0 to 18
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamStudies gut health in children during leukemia treatment
NCT06899581 · ClinicalTrials.gov
Countries: United Kingdom
- London, United Kingdom – Great Ormond Street Hospital
Ages 0 to 16
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamTests early palliative care for people with acute myeloid leukemia
NCT06848270 · ClinicalTrials.gov
Countries: Portugal
- Porto, Portugal – Centro Hospitalar e Universitário de São João
Up to age 70
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamTests drugs to prevent graft-versus-host disease after transplant in young blood cancer patients
NCT06756152 · ClinicalTrials.gov
Countries: Russia
- Moscow, Russia – National medical research center of pediatric haematology, oncology and immulogy named after Dmytriy Rogachyov
Ages 0 to 21
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamComparing two preparation treatments before stem cell transplant in children with leukemia
NCT05477589 · ClinicalTrials.gov
Countries: Belgium, Denmark, Spain and 7 more
- Brussels, Belgium – L'Hôpital Universitaire des Enfants Reine Fabiola (HUDERF)
- Brussels, Belgium – Cliniques Universitaires Saint-Luc (CUSL)
- Ghent, Belgium – Department of Pediatric Hematology, Oncology and SCT, Ghent University Hospital
Up to age 18
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamTests two treatment combinations in children and adolescents with acute myeloid leukemia
NCT01828489 · ClinicalTrials.gov
Countries: Belgium, Spain, Finland and 3 more
- Brussels, Belgium – Association Hospitaliere De Bruxelles Hopital Universitaire Des Enfants Reine Fabiola
- Leuven, Belgium – UZ Leuven
- Liège, Belgium – Centre Hospitalier Regional de la Citadelle
Up to age 64
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamStudying Bone Marrow Samples From Young People With Acute Myeloid Leukemia
NCT05772559 · ClinicalTrials.gov
Countries: France
- Amiens, France – CHU Amiens-Picardie - Site Sud
- Angers, France – CHU Angers
- Besançon, France – Hopital Minjoz
Up to age 25
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamCollects data and samples from patients with leukemia and related blood disorders
NCT05326919 · ClinicalTrials.gov
Countries: France
- Bobigny, France – Hopital Avicenne
- Paris, France – Hopital Saint Louis
- Paris, France – Hopital Robert Debre
No age limit given in the registry
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamTests Mylotarg, arsenic trioxide and retinoic acid in children with acute promyelocytic leukemia
NCT04793919 · ClinicalTrials.gov
Countries: Belgium, Czechia, Germany and 9 more
- Brussels, Belgium – Hôpital Universitaire des Enfants Reine Fabiola (Huderf)
- Brno, Czechia – Fakultni nemocnice Brno
- Prague, Czechia – Fakultni nemocnice v Motole
Up to age 18
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamTesting bone marrow and blood in children with relapsed or hard-to-treat leukemia
NCT04726241 · ClinicalTrials.gov
Countries: Australia, Canada, New Zealand and 2 more
- Parkville, Australia – Royal Children's Hospital
- Perth, Australia – Perth Children's Hospital
- South Brisbane, Australia – Queensland Children's Hospital
Up to age 22
Contact the trial teamCAR T cell treatment targeting CD70 in leukemia that has returned or persisted
NCT06345027 · ClinicalTrials.gov
Countries: United States
- Houston, United States – The Methodist Hospital
- Houston, United States – Texas Children's Hospital
Up to age 75
Contact the trial teamDrug combinations for newly diagnosed acute promyelocytic leukemia
NCT01409161 · ClinicalTrials.gov
Countries: United States
- Houston, United States – M D Anderson Cancer Center
- Houston, United States – MD Anderson Regional Care Center-Katy
- Nassau Bay, United States – MD Anderson Regional Care Center-Bay Area
Age 10 and over
Contact the trial teamTesting dexrazoxane to protect the heart during chemotherapy for blood cancers
NCT03589729 · ClinicalTrials.gov
Countries: United States
- Houston, United States – M D Anderson Cancer Center
Age 12 and over
Contact the trial teamTests a lower dose of cyclophosphamide after blood stem cell transplant
NCT05436418 · ClinicalTrials.gov
Countries: United States
- Bethesda, United States – National Institutes of Health Clinical Center
- Duarte, United States – City of Hope
Ages 12 to 120
Contact the trial teamDonor Bone Marrow Offered to Patients With Blood Cancers or Blood Disorders
NCT07145411 · ClinicalTrials.gov
Countries: United States
- Birmingham, United States – University of Alabama Birmingham
- Columbus, United States – The Ohio State University Medical Center
- Detroit, United States – Henry Ford Health
Ages 12 to 80
Contact the trial teamTests pexidartinib in young people with refractory leukemias and solid tumors
NCT02390752 · ClinicalTrials.gov
Countries: United States
- Bethesda, United States – National Institutes of Health Clinical Center
Ages 3 to 35
Contact the trial teamTests natural killer cell therapy after cord blood transplant in blood cancers
NCT02727803 · ClinicalTrials.gov
Countries: United States
- Houston, United States – M D Anderson Cancer Center
Ages 15 to 80
Contact the trial team
Showing 40 of 213. Use the filters to narrow the list.
How to get into an early trial
- A lab does not treat patients, so you cannot phone the lab to get a new treatment.
- Ask your doctor to look at phase 1 trials with you. These are the first tests in people.
- If one fits, your doctor sends a referral to the trial centre.
- The trial team checks whether you can join and decides.
Trial data: ClinicalTrials.gov, courtesy of the U.S. National Library of Medicine; it does not endorse this site. EU trials: EU Clinical Trials Information System (CTIS), European Medicines Agency. We show the registry records; the trial team has the last word on who can join.
Latest research
The five newest articles. The label comes from the PubMed index: whether it was tested in people, in animals or only in the lab.
- Higher Relapse Rate and Resource Utilization With Ara-C Consolidation Chemotherapy Alone Compared to Hematopoietic Cell Transplantation in First Remission in a Cohort of Younger Adults With Acute Myeloid Leukemia With t(8;21) (q22;q22.1).J Hematol · 2026-10-31
- In animalsAll-Trans Retinoic Acid-Loaded Fe-N3-Se Single-Atom Nanozymes Enable Redox-Guided Differentiation Therapy for Acute Myeloid Leukemia.ACS Nano · 2026-11-17
- In animalsIntravital Microscopy-Guided Live-Cell Isolation for Spatially Resolved Transcriptional Analysis of Leukemia-Immune Interactions.J Vis Exp · 2026-11-10
- Impact of Molecular and Cytogenetic Risk Stratification, Early Treatment Response, and Inflammatory Biomarkers on Survival in Intensively Treated Non-Acute Promyelocytic Leukemia Acute Myeloid Leukemia.World J Oncol · 2026-11-11
- In peopleEarly bone marrow-guided venetoclax management in frontline unfit acute myeloid leukemia: a two-stage real-world study.Ann Hematol · 2026-08-20
Is it true?
Saw something on social media? Fact-check it now.
Get screened
For family members and people at higher risk: free checks can find some cancers early, before there are symptoms.
There is no routine screening for this cancer. If you have symptoms or a family history, talk to your doctor.
If several people in your family had cancer, ask your GP whether genetic counselling makes sense for you.
Offer tissue or data
You can help research move faster.
Give tissue or blood to research
Before an operation or a blood test, ask if left-over tissue or blood can go to a biobank.
- Does this hospital have a biobank?
- What will the sample be used for, and for how long?
- Can I change my mind later?
Share your health data
Ask your doctor whether there is a patient registry for your illness. You choose what you share.
Take part as a healthy volunteer
Some studies need people without the illness, often family members.
Volunteer studiesGet support
Patient groups in Austria
- Österreichische Krebshilfe
Free, anonymous counselling at regional centres in every federal state, psycho-oncology and emergency financial aid.
Phone: 01 7966450
Help for every illness in Austria (4)
- 1450 – Rund-um-die-Uhr-Gesundheitsberatung
Austria's nationwide 24/7 telephone health advice line: trained staff assess symptoms and guide callers to the appropriate care.
- Telefonseelsorge Österreich – Notruf 142
Free, confidential 24/7 emotional support and crisis line for anyone in Austria, reachable on 142.
- Gesundheitsportal Österreich (gesundheit.gv.at)
Austria's official public health portal, offering quality-assured information on diseases, prevention, health services and patient rights.
- ARGE Selbsthilfe Österreich
ARGE Selbsthilfe Österreich represents the interests of self-help groups and patient organisations in Austrian social and health policy.
Available abroad: international groups (8)
- DKMS
Finds blood stem cell donors worldwide so that people with blood cancer can have a transplant.
- Acute Leukemia Advocates Network (ALAN)
Global network of 69 acute leukaemia patient organisations (hosted by the Swiss Leukemia Patient Advocates Foundation); member list helps patients find a national group.
- European Cancer Patient Coalition (ECPC)
Umbrella of European cancer patient groups, with a patient toolbox and a legal network for cancer patients.
- European Reference Networks (European Commission)
The European Commission's 24 expert networks for rare and complex diseases; your doctor can contact them.
- EURORDIS – Rare Diseases Europe
Alliance of over 1,000 rare disease patient organisations, with a list of rare disease helplines by country.
- Workgroup of European Cancer Patient Advocacy Networks
Network of pan-European cancer patient umbrella groups (including the blood cancer networks): joint advocacy, WECAN Academy training for patient advocates, patient experience data courses.
- European Patients' Forum (EPF)
Umbrella of European patient organisations and national patient coalitions.
- International Alliance of Patients' Organizations
Global alliance of patient organisations of all diseases, promoting patient-centred healthcare.
Money and work
If the illness stops you working, ask the hospital social worker which benefits you can claim.
- Which sick-pay or disability benefits can I apply for?
- Is there help for the carer in the family?
- Are travel costs to treatment paid back?
After a loss
If someone you love has died, you do not have to go through it alone. Many families ask themselves whether they missed something; the care team can talk this through with you.
We have no grief support group in Austria in our list yet. The hospital's social worker or palliative team can tell you where to find one.
Hospitals and hospices have chaplains and counsellors, for any faith or none.
Some families decide to give tissue to research after death, so that the illness can be studied. If you want to, ask the treating hospital early whether it has such a programme.
Access and cost
- If no trial fits, your doctor can ask the company and the medicines authority whether early access (compassionate use) is possible.
- In Austria the medicines agency BASG lists the early-access programmes that are running. BASG (Austria): list of compassionate use programmes, no. 054
- In the EU you may get planned care in another EU country. Ask your health insurer before you go. Your Europe: planned medical treatment abroad
- Some medicines for this disease are approved abroad but maybe not here: see “Approved elsewhere” under “Approved in Austria” above.
Don't pay for this
No one will cure you through a Facebook message or ask you to invest money.
- Animal worm medicines bought online (ivermectin, fenbendazole)
They are made for animals and not tested for cancer in people. High doses can cause seizures or coma, fenbendazole has caused liver damage, they may weaken your cancer treatment, and they can keep you out of a trial.
American Cancer Society: What to Know About Ivermectin (21 May 2026) · American Cancer Society: What to Know About Fenbendazole (21 Oct 2025) · ASCO: Oncologists urged to discuss ivermectin and fenbendazole (17 Jun 2026)
- “Treatment plans” offered in comments
Ask which published study in people is behind it. Usually there is none.
- Anyone who answers your post with a private treatment
Real trials are listed in a public registry. Check the number on ClinicalTrials.gov or the EU trial register.
- Strangers offering investments or “funds” for treatment
Do not reply and do not send money. Report the comment or message.
Before you pay for anything, ask three things
- Can I have a written price, with everything that is included?
- Which published study in people shows it helps my disease?
- What does my doctor say about it?
Questions for your doctor
Ready lists for a new diagnosis, during treatment, before a trial and before you pay. Open the question lists
Not medical advice. We show what is open and what is known; your care team decides what fits you.